Back to Journals » International Journal of Nanomedicine » Volume 11

A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepacia

Authors Klinger-Strobel M, Ernst J, Lautenschlaeger C, Pletz MW, Fischer D, Makarewicz O

Received 15 October 2015

Accepted for publication 18 November 2015

Published 5 February 2016 Volume 2016:11 Pages 575—583

DOI https://doi.org/10.2147/IJN.S98401

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Govarthanan Muthusamy

Peer reviewer comments 3

Editor who approved publication: Dr Thomas J Webster

Mareike Klinger-Strobel,1,2,* Julia Ernst,3,* Christian Lautenschläger,4 Mathias W Pletz,1,2 Dagmar Fischer,3,5 Oliwia Makarewicz1,2


1Center for Infectious Diseases and Infection’s Control, 2Center for Sepsis Control and Care, Jena University Hospital, 3Department of Pharmaceutical Technology, Friedrich Schiller University Jena, 4Department of Internal Medicine IV, Jena University Hospital, 5Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Jena, Germany

*These authors contributed equally to this work


Abstract: Strategies that target and treat biofilms are widely applied to bacterial cultures using popular live/dead staining techniques with mostly red or green fluorescent markers (eg, with SYTO® 9, propidium iodide, fluorescein). Therefore, visualizing drugs or micro- and nanoparticulate delivery systems to analyze their distribution and effects in biofilms requires a third fluorescent dye that does not interfere with the properties of the live/dead markers. The present study establishes and evaluates a model for tracking polymeric particles in fluorescently stained biological material. To this end, poly(D,L-lactide-co-glycolide) (PLGA)-based micro- and nanoparticles were used as well-established model systems, which, because of their favorable safety profiles, are expected to play important future roles with regard to drug delivery via inhalation. PLGA was covalently and stably labeled with 7-amino-4-methyl-3-coumarinylacetic acid (AMCA), after which blue fluorescent poly(ethylene glycol)-block-PLGA (PEG-PLGA) particles were prepared using a mixture of fluorescent AMCA-PLGA and PEG-PLGA. Because chitosan is known to reduce negative surface charge, blue fluorescent PEG-PLGA-particles with chitosan were also prepared. These micro- and nanoparticles were physicochemically characterized and could be clearly distinguished from live/dead stained bacteria in biofilms using confocal laser scanning microscopy.

Keywords: 7-amino-4-methyl-3-coumarinylacetic acid, PLGA, PEG, confocal laser scanning microscopy, cystic fibrosis, chitosan, hydrodynamic diameter

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody

Saeed M, van Brakel M, Zalba S, Schooten E, Rens JAP, Koning GA, Debets R, ten Hagen TLM

International Journal of Nanomedicine 2016, 11:955-975

Published Date: 8 March 2016

Three-dimensional culture and interaction of cancer cells and dendritic cells in an electrospun nano-submicron hybrid fibrous scaffold

Kim TE, Kim CG, Kim JS, Jin S, Yoon S, Bae HR, Kim JH, Jeong YH, Kwak JY

International Journal of Nanomedicine 2016, 11:823-835

Published Date: 2 March 2016

The potential applications of fibrin-coated electrospun polylactide nanofibers in skin tissue engineering

Bacakova M, Musilkova J, Riedel T, Stranska D, Brynda E, Zaloudkova M, Bacakova L

International Journal of Nanomedicine 2016, 11:771-789

Published Date: 25 February 2016

Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application

Alwani S, Kaur R, Michel D, Chitanda JM, Verrall RE, Karunakaran C, Badea I

International Journal of Nanomedicine 2016, 11:687-702

Published Date: 19 February 2016

Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis

Saidykhan L, Abu Bakar MZ, Rukayadi Y, Kura AU, Latifah SY

International Journal of Nanomedicine 2016, 11:661-673

Published Date: 15 February 2016

Cytoprotective effect of glutaraldehyde erythropoietin on HEK293 kidney cells after silver nanoparticle exposure

Sooklert K, Chattong S, Manotham K, Boonwong C, Klaharn I, Jindatip D, Sereemaspun A

International Journal of Nanomedicine 2016, 11:597-605

Published Date: 12 February 2016

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications

Kalomiraki M, Thermos K, Chaniotakis NA

International Journal of Nanomedicine 2016, 11:1-12

Published Date: 22 December 2015

Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells

Roy K, Patel YS, Kanwar RK, Rajkhowa R, Wang X, Kanwar JR

International Journal of Nanomedicine 2016, 11:25-44

Published Date: 21 December 2015